Literature DB >> 23716580

Senescent T cells and hypertension: new ideas about old cells.

Meena S Madhur, David G Harrison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23716580      PMCID： PMC3734939          DOI： 10.1161/HYPERTENSIONAHA.113.01410

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  13 in total

1.  Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation.

Authors:  Michael W Brands; Amy K L Banes-Berceli; Edward W Inscho; Hind Al-Azawi; Ashlyn J Allen; Hicham Labazi
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

Review 2.  Granzymes at a glance.

Authors:  Michael Bots; Jan Paul Medema
Journal:  J Cell Sci       Date:  2006-12-15       Impact factor: 5.285

3.  Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension.

Authors:  Antony Vinh; Wei Chen; Yelena Blinder; Daiana Weiss; W Robert Taylor; Jörg J Goronzy; Cornelia M Weyand; David G Harrison; Tomasz J Guzik
Journal:  Circulation       Date:  2010-11-29       Impact factor: 29.690

4.  T cells and blood vessels: costimulation turns up the pressure.

Authors:  De-Xiu Bu; Andrew H Lichtman
Journal:  Circulation       Date:  2010-11-29       Impact factor: 29.690

5.  Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis.

Authors:  Jose Herrera; Atilio Ferrebuz; Ernesto García MacGregor; Bernardo Rodriguez-Iturbe
Journal:  J Am Soc Nephrol       Date:  2006-12       Impact factor: 10.121

6.  Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension.

Authors:  Jong-Chan Youn; Hee Tae Yu; Beom Jin Lim; Myoung Ju Koh; Jino Lee; Dong-Yeop Chang; Yoon Seok Choi; Sang-Hak Lee; Seok-Min Kang; Yangsoo Jang; Ook Joon Yoo; Eui-Cheol Shin; Sungha Park
Journal:  Hypertension       Date:  2013-05-28       Impact factor: 10.190

Review 7.  Immune and inflammatory mechanisms in pulmonary arterial hypertension.

Authors:  Hala El Chami; Paul M Hassoun
Journal:  Prog Cardiovasc Dis       Date:  2012 Sep-Oct       Impact factor: 8.194

8.  Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension.

Authors:  L E Bautista; L M Vera; I A Arenas; G Gamarra
Journal:  J Hum Hypertens       Date:  2005-02       Impact factor: 3.012

Review 9.  CD28(-) T cells: their role in the age-associated decline of immune function.

Authors:  Nan-Ping Weng; Arne N Akbar; Jorg Goronzy
Journal:  Trends Immunol       Date:  2009-06-18       Impact factor: 16.687

10.  Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

Authors:  Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190
View more
  7 in total

1.  Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19.

Authors:  Saskia Trump; Soeren Lukassen; Markus S Anker; Robert Lorenz Chua; Johannes Liebig; Loreen Thürmann; Victor Max Corman; Marco Binder; Jennifer Loske; Christina Klasa; Teresa Krieger; Bianca P Hennig; Marey Messingschlager; Fabian Pott; Julia Kazmierski; Sven Twardziok; Jan Philipp Albrecht; Jürgen Eils; Sara Hadzibegovic; Alessia Lena; Bettina Heidecker; Thore Bürgel; Jakob Steinfeldt; Christine Goffinet; Florian Kurth; Martin Witzenrath; Maria Theresa Völker; Sarah Dorothea Müller; Uwe Gerd Liebert; Naveed Ishaque; Lars Kaderali; Leif-Erik Sander; Christian Drosten; Sven Laudi; Roland Eils; Christian Conrad; Ulf Landmesser; Irina Lehmann
Journal:  Nat Biotechnol       Date:  2020-12-24       Impact factor: 54.908

Review 2.  The immunological basis of hypertension.

Authors:  Bernardo Rodríguez-Iturbe; Héctor Pons; Yasmir Quiroz; Richard J Johnson
Journal:  Am J Hypertens       Date:  2014-08-23       Impact factor: 2.689

Review 3.  Immune mechanisms in hypertension.

Authors:  Carolina De Ciuceis; Claudia Rossini; Elisa La Boria; Enzo Porteri; Beatrice Petroboni; Alice Gavazzi; Annamaria Sarkar; Enrico Agabiti Rosei; Damiano Rizzoni
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-01-21

Review 4.  T cell senescence and cardiovascular diseases.

Authors:  Hee Tae Yu; Sungha Park; Eui-Cheol Shin; Won-Woo Lee
Journal:  Clin Exp Med       Date:  2015-07-19       Impact factor: 3.984

Review 5.  COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes.

Authors:  Banafsheh Bigdelou; Mohammad Reza Sepand; Sahar Najafikhoshnoo; Jorge Alfonso Tavares Negrete; Mohammed Sharaf; Jim Q Ho; Ian Sullivan; Prashant Chauhan; Manina Etter; Tala Shekarian; Olin Liang; Gregor Hutter; Rahim Esfandiarpour; Steven Zanganeh
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

6.  Psychoneuroimmunological aspects of cardiovascular diseases: a preliminary report.

Authors:  Dagmara Bartczak; Łukasz Szymański; Paweł Bodera; Wanda Stankiewicz
Journal:  Cent Eur J Immunol       Date:  2016-07-15       Impact factor: 2.085

Review 7.  Adaptive Immunity in Hypertension.

Authors:  Tomasz P Mikolajczyk; Tomasz J Guzik
Journal:  Curr Hypertens Rep       Date:  2019-07-18       Impact factor: 5.369
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.